Peptide Codes Forum

so ive been running ipamorelin/cjc combo for like 4 months now and always did subQ in the stomach fat pinch like everyone says to do. got decent results but felt like maybe i was leaving gains on the table ya know? decided to experiment and switch to IM in the delt for a few weeks to see if theres actually a difference

first thing i noticed was the absorption speed is NOT the same lol. IM hits way faster like you can almost feel the GH pulse come on quicker. subQ feels more of a slow steady release situation. for GHRPs and GHRH combos this actually matters because the timing of the pulse is kinda the whole point

downside of IM tho - got some pip at the injection site that i never got doing subQ. nothing crazy but def more soreness the next day especially with cjc. also used way shorter pins for subQ (5/16 inch) and switched to 1 inch for IM which feels more intimidating ngl

my honest take after comparing both for a couple months is that subQ is probably fine for most peptides and way more forgiving if ur not super lean. if ur carrying extra bodyfat the subQ depot can slow absorption even more which might actually be whats been happening with my protocol

anyone else experimented with this or am i overthinking it lol

gainz_peptide_bro wrote:first thing i noticed was the absorption speed is NOT the same lol. IM hits way faster like you can almost feel the GH pulse come on quicker. subQ feels more of a slow steady release situation. for GHRPs and GHRH combos this actually matters because the timing of the pulse is kinda the whole point

Your observations here are entirely consistent with what the pharmacokinetic literature would predict. The difference in vascularization between subcutaneous adipose tissue and skeletal muscle is the primary driver of that differential absorption rate you noticed. Intramuscular tissue has significantly higher blood flow per unit volume compared to subcutaneous fat, which naturally accelerates Cmax and shortens Tmax for peptides administered via that route.

What I find particularly interesting in your writeup is the point about body composition affecting subQ absorption. This is underappreciated in most community discussions. Adipose tissue thickness directly influences the diffusion distance to capillary beds, and individuals carrying higher body fat percentages may indeed experience attenuated or delayed pulse characteristics from subQ administration. There is some indirect support for this in the broader peptide pharmacokinetics literature, though I would note that most formal studies on GHRPs and GHRH analogs like ipamorelin and CJC-1295 use standardized injection protocols that do not always account for this variable.

The question I would ask you to consider going forward: were your injection times relative to sleep and meals held constant when you were comparing the two routes? That confound could meaningfully muddy the attribution of any differences you observed to route of administration specifically.

The PIP with CJC is not surprising either given the pH and osmolality of reconstituted solutions. Worth mentioning for anyone reading.